The heart attack epidemic in India – what changed in 2021? Vaccination

(50+ papers listing cardiac problems with AZ/Covishield/Chadox1 at the end of the article)

Lets ignore the newly named VITT – devastating clots and GBS already linked to the adenovirus-vec vaccine.

There has been a cardiac-arrest epidemic in India since 2021 (Mumbai .. Kolkata).

“Mumbai witnessed an over six-fold rise in monthly deaths related to heart attack in the first six months of 2021 compared to previous years. Between January and June 2021, as many as 3,000 people lost their lives to heart attacks every month in the city, compared to 500 in 2020.”

The signs were there so early, Mar 2021 – someone dying in 15 mins after the vax with “congestive heart failure ” and still they say “not due to vaccine reaction”.

Many think it is being caused by the Cov2 virus – then why did we not hear this in 2020, when a significant % of the population was infected?

What has happened since then?

Vaccination of a significant % of the population with the adenovirus-vec-vaccine (long dumped by the West). And adenoviruses are an “important cause of heart muscle infection and heart muscle dysfunction“.

Heart-cells express a receptor called CAR (in fact it is named after adenoviruses). If the vaccine enters these cells and make Cov2 spike protein (as by design), then the immune-system will attack and destroy these cells.

Like this paper from Germany “found “Evidence of SARS-CoV-2 spike protein in cardiac tissue after COVID-19 vaccination” by immunohistochemical stainings”

And heart cells don’t regenerate in humans.

Latency

What is the risk period after the vaccination – sometimes it is months, even one year.

Papers listing cardiac problems with AZ/Covishield/Chadox1

Excluding the much more dangerous VITT and GBS

1. Korea – after Chadox1 , 63-year F “developed chest pain as an initial symptom 3 hours after the 2nd shot” had “heart transplantation” died 54 days later of pneumonia
2. India, Andhra: Autopsies in AP, India “All six cases had received Covishield” (see why I focus more on this) “Three cases had pathology in the kidney, two cases showed pathology in the heart and one case showed pulmonary oedema in both lungs.”
3. India 63, M, Myocardial infarction: “He had history of taking first dose of Covishield vaccine 2 days back and since then he developed uneasiness, dizziness and excessive sweating.”
4. India, Three cases of Acute cornary syndrome (term used to describe a range of conditions associated with sudden, reduced blood flow to the heart.)
5. India, 68M, “Acute Myocardial Infarction After COVID-19 Vaccination: A Case Report”
6. “Two case reports of acute ST-elevation myocardial infarction after COVID-19 vaccination: Co-incidence or causal-association?” – within 30 mins and 20 hrs
7. Taiwan, 75F: “Myocardial Infarction and Azygos Vein Thrombosis”
8. Korea: “deceased was a 69-year-old woman who complained of nonspecific symptoms shortly after vaccination and was found dead on the sixth day” (Acute Myocardial Infarction with Microthrombi in Cardiac Small Vessels)
9. Taiwan: “Acute ST-Segment Elevation Myocardial Infarction After ChAdOx1 nCoV-19 Vaccination in a 33-Year-Old Man“, Although his platelet count and fibrinogen and D-dimer levels began to improve with plasma exchanges, his condition deteriorated, he had multiple organ failures, and he succumbed on day 14 of hospitalization.
10. UK: “A 40-year-old man with no cardiac history presented with central chest pain 8 days after receiving the ChAdOx1 nCov-19 vaccine“
11. Taiwan, 44F : “Acute Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccine” 2 days after
12. Kenya: “36-year-old lady who was treated for severe COVID-19 pneumonia 4 months before she got her first COVID-19 Astra Zeneca vaccine. She then developed severe chest pain 2 weeks after the first dose of the vaccine and a recurrence a month later after the first episode of the myopericarditis.”
13. Iran, 70M: “Long QT interval and syncope after a single dose”, 3 days after
14. Thailand: 55 yr F, “adenoviral vector coronavirus disease 2019 vaccine could possibly cause myocarditis and painless thyroiditis.”
15. Iran: 32F, “developed inappropriate exertional tachycardia and exertional dyspnea from Day 3 and was diagnosed with myocarditis by subsequent echocardiography about 3 months later.”
16. Germany 68F, “acute chest pain with radiation to her left shoulder. The rapid troponin test was positive; hence, after oral nitroglycerin administration, she was immediately referred to our emergency department. Noteworthy, this lady had been vaccinated with first dose of AstraZeneca the previous day“
17. Taiwan: 23M,”A case of myopericarditis with pleuritis“, after 1 week
18. Singapore: 4 cases, within 14 days
19. Taiwan, 60M: “Acute ST-Segment Elevation Myocardial Infarction Happened Within 2 Hours after First Dose of COVID-19 Vaccine“
20. Iran: “The patient was a 26-year-old man without any history of the underlying disease with typical chest pain which spread to the back and left arm; he was diagnosed with myocarditis after the second dose of the AstraZeneca vaccine.“
21. Iran: “A 20-year-old man with a history of multiple sclerosis (clinically isolated syndrome-CIS) with a BMI of 22.4 kg/m2 was admitted to the hospital to visit due to recent retrosternal chest pain (2 episodes of 30 minutes in the morning and evening), 4 days after the third dose of SARS-COV-2 vaccine (AstraZeneca vaccine). Moreover, he had received the rst and second dose of the SARS-COV-2 vaccine (Sinopharm vaccine) 5 and 4 months before.“
22. Germany: “A case of myocarditis after COVID-19 vaccination: incidental or consequential?” 29,M – “he had received a SARS-CoV-2-vaccination (Vaxzevria, Astra Zeneca) three days earlier. The patient had a medical history no known chronic illnesses or allergies and had not been using any medication.”
23. Germany: “Patient number 4, a healthy 18-year-old male received the first dose of Vaxzevria (AstraZeneca) at the end of June 2021. The patient reported new episodes of chestpain and discomfort and exercise limitation ~10 days after the vaccination. Initially, no medical presentation was made in the expectation that the symptoms would disappear.”
24. Mexico: “A 42-year-old male with history of dyslipidaemia was evaluated due to myalgias, palpitations, and dyspnoea 48 h after receiving a COVID-19 vaccine booster (ChAdOx1 nCoV-19 or AZD1222). Patient had previously received two doses of Pfizer-BioNTech vaccine.“
25. Germany “And found “Evidence of SARS-CoV-2 spike protein in cardiac tissue after COVID-19 vaccination” by immunohistochemical stainings”
26. Germany “We present the first case of CMV reactivation and pericarditis in temporal association with SARS-CoV-2 vaccination” (a different mechanism)
27. India: Wardha, Maharashtra, India “Myocardial infarction rarely happens in young age…. 21-year-old patient who presented with myocardial infarction 14 days after receiving the ChAdOx1“
28. Australia: “We report the first known case of takotsubo (stress) cardiomyopathy 4 days after administration of the ChAdOx1 nCoV-19 vaccine in a 72-year-old man.”
29. UK , early 50’s, F “Novel case of takotsubo cardiomyopathy following COVID-19 vaccination”
30. Thailand “a 31-year-old female patient who presented with fever, myalgia, arthralgia, pleuropericarditis, leukocytosis, and transaminitis following ChAdOx1 vaccination,” – after two doses of Coronavac
31. Australia – “We present the case of a 63-year-old female who developed severe retrosternal chest pain nine days after receiving her first dose of the ChAdOx1 nCoV-19 vaccination.”
32. Taiwan: “We presented a 94-year-old man with rapidly progressive dyspnea and fatigue six days after his first ChAdOx1 nCoV-19 vaccination. Impending cardiac tamponade…”
33. Australia: 29M, “With a diagnosis of autonomic dysfunction/postural orthostatic tachycardia syndrome”
34. Chile – 2 doses of Coronavac (inactivated like Covaxin), nothing. Then booster of Covishield – 2 weeks later, heart problems…
35. UK, 54 M – died. “We present a case of 54-year-old patient who presented with chest and abdominal pain for 12 hours and evidence of infero-lateral ST segment elevation on electrocardiogram.
36. India, Delhi, 70 year old F, Covishield.. “She developed an intracranial bleed a few hours after vaccination.”..Also, she suffered cardiac arrest for which resuscitation was done…6days after the vaccination, she succumbed to her state” .. Received 2021 May 26; Accepted 2021 Jun 26. Published online 2022 Apr 7 (A YEAR LATER) – the 2nd wave in India ..
37. Germany, 63F – “Ventricular tachycardia triggered by the first dose of an adenoviral vector- based COVID- 19 vaccine in an adult patient with congenital heart disease”
38. Taiwan, 85 M – “He visited the clinic of cardiology with chest discomfort, palpitation, and dyspnea after 1 week of AZ COVID-19 vaccination.”
39. Uk 72M, 4 days after- “Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination”
40. Oman – 3 cases, one was 28M who died, onset 4 days after – “however, he deteriorated, became severely hypotensive with bradycardia, and died three days after admission”
41. Korea 22F, – “Ten days after receiving the first dose of coronavirus disease vaccine, a 22-year-old woman in South Korea experienced myocarditis, myopathy, pericarditis, and gastroenteritis; rash subsequently developed”
42. UK: “Patient 1 was admitted with a posterior-inferior ST-elevation myocardial infarction”
43. Taiwan, 44M – died – “In conclusion, we present a man in his prime who developed fulminant myositis, rhabdomyolysis, and renal failure after ChAdOx1-nCoV-19 vaccination”
44. Korea – “63-year-old woman with no relevant medical history. She presented symptoms of nausea, fatigue, and headache immediately after vaccination. Ten days after vaccination, she suddenly started vomiting and developed high blood pressure. The patient eventually died 23 days after vaccination”
45. Italy: 68M, “Here, we report on a case of fatal rhabdomyolysis that occurred 9 days after vaccination for ChAdOx1 nCov-19, complicated by a multiorgan failure involving bone marrow, liver, kidney, and lung in a previously healthy subject.”
46. Austria, “58-year-old man presented to his practitioner with right-sided pleuritic chest pain, dyspnea, and fatigue 18 days following the first dose of the ChAdOx1 nCov-19 vaccine.
47. Australia: 38 M, “Acute near-fatal multisystem inflammatory syndrome and fulminant myocarditis post ChAdOx1 nCoV-19 vaccination in a SARS-CoV-2 naïve individual”
48. Taiwan – “had a cardiopulmonary arrest 2 min after receiving the Oxford- AstraZeneca (ChAdOx1 nCoV-19)”
49. Saudi Arabia – pericarditis “A 48-year-old healthy male presented nine days after receiving the first dose of COVID-19 AstraZeneca vaccine”
50. Brazil – 46 year old, heart transplant patient – 15 days after – “As he had increased troponin and new left ventricular dysfunction”
51. Tunisia – 41 male, myocarditis 21 days after 1st dose
52. UK – “52-year-old man presented with progressively worsening swelling of the face, neck, chest and arms, pleuritic chest pain”, 5 weeks after
53. Taiwan: “A 49-year-old man developed an acute myocardial infarction 3 weeks after receiving his first dose of ChAdOx1 nCoV-19 in June 2021. Three months later, he presented with right third toe wet gangrene with extension into the plantar foot nine days after receiving his second dose of ChAdOx1 nCoV-19 vaccine.”
54. Italy – 2 cases – “”COVID-19 vaccination induces a particular form of pericarditis, often insidious and very troublesome, but with good prognosis.”
55. Korea – 49 year old “After a month of rehabilitation therapy, he recovered significantly to the extent of using a wheelchair. But one week later, he experienced an episode of cardiac arrest when he was tilted while undergoing physical therapy”
56. Germany – “61-year-old male. He had received his first injection of Vaxzevria (AstraZeneca) 3 days before death…The emergency doctor detected severe bradycardia and was unable to re-establish sufficient cardiocirculatory function. The autopsy revealed excessive left heart myocardial hypertrophy, severe coronary disease, and old myocardial scars due to previous infarctions. Sudden heart failure was regarded as the cause of death.”
57. Morocco: “We report two cases of acute symptomatic myocarditis occurring after the second dose of Vaxzevria vaccine (Oxford/AstraZeneca vaccine), in the absence of any clinical, biological or radiological evidence of concomitant SARS-CoV-2 infection and a negative etiological investigation.:

All Adenovirus-vaccines are lethal – J&J (Ad26)

1. Spain: 51M, “sudden cardiac death”, J&J ” Furthermore, he had received the first dose of the vaccine Ad26.COV2.S (Janssen®) against COVID-19 48 h ago”
2. US – “A previously healthy 33-year-old male presented to the emergency department with acute onset substernal chest pain. Two days prior, he had received the Janssen Ad26.COV2·S vaccine”
3. Italy – ACUTE MYOCARDITIS FOLLOWING COVID-19 VACCINATION: A PECULIAR CASE SERIES “Four patients received an mRNA vaccine (Comirnaty or Spikevax) and one received the adenovirus vaccine (Janssen).”
4. Poland – “A 19-year-old previously healthy male arrived at the emergency department presented with a chief complaint of non-radiating chest pain of 3 days duration… He reported receiving the second dose of the COVID-19 Janssen vaccine 4 days before the symptoms.”
5. Germany = “59-year-old male resident of a nursing home. He was physically disabled due to multisystem atrophy and had received his first dose of COVID-19 Vaccine Janssen (Johnson & Johnson). Four days after the injection he developed a severe disturbance of consciousness including confusion. Shortly afterwards he was found dead”